Repurposing Tin Mesoporphyrin as an Immune Checkpoint Inhibitor Shows Therapeutic Efficacy in Preclinical Models of Cancer. (2018)
Attributed to:
Interactions between mesencyhmal stromal cells and macrophages in the progression of cancer.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/1078-0432.ccr-17-2587
PubMed Identifier: 29339440
Publication URI: http://europepmc.org/abstract/MED/29339440
Type: Journal Article/Review
Volume: 24
Parent Publication: Clinical cancer research : an official journal of the American Association for Cancer Research
Issue: 7
ISSN: 1078-0432